International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

Thoracic oncology: from fusion genes to treatment

Symposium
Chairs: Jacques Cadranel (Paris, France), Jean-Paul Sculier (Brussels, Belgium)
Aims: To discuss the different fusion genes, the current diagnostic and treatment practices, and the future challenges and opportunities in advancing outcomes for patients with fusion gene lung cancers.
Target audience: Clinicians, surgeons, radiation oncologists, and pathologists involved in lung cancer.

Download all media

The key role of pulmonologists in ALK+ NSCLC care Jacques Cadranel (Paris, France)
Identification techniques Marcin Skrzypski (Sopot, Poland)
Drugs that target fusion genes Giulio Metro (Perugia, Italy)
Management of patients with a tumoural fusion gene Thierry Berghmans (Brussels, Belgium)